Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Hospital Pediatrics|May 3, 2022
Improving Timely Discharges Through Nurse-Initiated Conditional Discharge OrdersLynsey Vaughan, Tara Neary, Paul ManiconePlos One|December 14, 2011
miRNA expression profiling of the murine TH-MYCN neuroblastoma model reveals similarities with human tumors and identifies novel candidate miRNAsMarta Terrile, Kenneth Bryan, Lynsey Vaughan, et al.Cell Reports|December 29, 2014
HUWE1 ubiquitylates and degrades the RAC activator TIAM1 promoting cell-cell adhesion disassembly, migration, and invasionLynsey Vaughan, Chong-Teik Tan, Anna Chapman, et al.Molecular Cancer Therapeutics|September 3, 2011
The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivoAmir Faisal, Lynsey Vaughan, Vassilios Bavetsias, et al.Radiology|November 22, 2012
Evaluation of clinically translatable MR imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastomaYann Jamin, Elizabeth R Tucker, Evon Poon, et al.Oncotarget|July 21, 2016
Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumorsLynsey Vaughan, Paul A Clarke, Karen Barker, et al.EMBO Molecular Medicine|December 23, 2016
HUWE1 is a critical colonic tumour suppressor gene that prevents MYC signalling, DNA damage accumulation and tumour initiationKevin B Myant, Patrizia Cammareri, Michael C Hodder, et al.Pageof 1